Abstract
We examine the role of different network capabilities of companies that influence the formation of R&D partnerships in pharmaceutical biotechnology. Strategic network capabilities, specifically centrality-based capabilities and the efficiency with which companies choose their partners, are found to facilitate the formation of new partnerships. Unlike general experience with partnering, these strategic network capabilities play a crucial role in enabling companies to continue to interact with other companies through partnerships in a complex network setting.
| Original language | English |
|---|---|
| Pages (from-to) | 39-53 |
| Journal | British Journal of Management |
| Volume | 17 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2006 |